Peter Attia· MD
not just in terms of longevity but also of recent note their potential for reducing the risk of saros cov2 infection or other infections and of course covet 19 morbidity and we speculate on those things to a great deal
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
not just in terms of longevity but also of recent note their potential for reducing the risk of saros cov2 infection or other infections and of course covet 19 morbidity and we speculate on those things to a great deal
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.